Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Open-label, Single-arm 24-hour Ambulatory Blood Pressure Monitoring (ABPM) Study of Testosterone Cypionate Injection in Hypogonadal Men

NCT07328542 is registered in ClinicalTrials.gov with Azurity Pharmaceuticals as lead sponsor.

NCT NCT07328542
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07328542 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Open-label, Single-arm 24-hour Ambulatory Blood Pressure Monitoring (ABPM) Study of Testosterone Cypionate Injection in Hypogonadal Men
Lead sponsor
Azurity Pharmaceuticals
Phase
Phase 4
Overall status
Not yet recruiting
Start date
February 28, 2026
Completion date
August 31, 2027
Enrollment
144 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hypogonadism, male